Literature DB >> 1184396

Ehlers-Danlos syndrome in two siblings with deficient lysyl hydroxylase activity in cultured skin fibroblasts but only mild hydroxylysine deficit in skin.

B Steinmann, R Gitzelmann, A Vogel, M E Grant, R Harwood, C H Sear.   

Abstract

Two siblings suffered from Ehlers-Danlos syndrome characterized by skin fragility, joint laxity and dermal hyperelasticity. The association with microcornea and muscle hypotonia allowed the preliminary classification into type VI according to McKusick. Ultrastructure analysis of skin biopsies revealed poor integration of collagen fibrils into fibres; accordingly, the texture of the connective tissue appeared irregular. Lysyl hydroxylase activity of cultured skin fibroblasts was markedly reduced in the cells of the two patients. Preliminary studies revealed intermediate activity in the cells cultured from the skin of the parents. This finding suggested an autosomal recessive mode of inheritance. Unexpectedly and in contrast to the 3 cases reported in the literature, the hydroxylysine deficit in the patients' skin was, for reasons not yet understood, only mild. Therefore, amino acid analysis of skin is not adequate for the diagnosis of lysyl hydroxylase-deficient Ehlers-Danlos syndrome type VI.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1184396

Source DB:  PubMed          Journal:  Helv Paediatr Acta        ISSN: 0018-022X


  19 in total

1.  The origin of urinary hydroxylysyl glycosides in Paget's disease of bone and in primary hyperparathyroidism.

Authors:  R Askenasi; M De Backer; A Devos
Journal:  Calcif Tissue Res       Date:  1976-11-24

2.  The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations.

Authors:  Andreas R Janecke; Ben Li; Manfred Boehm; Birgit Krabichler; Marianne Rohrbach; Thomas Müller; Irene Fuchs; Gretchen Golas; Yasuhiro Katagiri; Shira G Ziegler; William A Gahl; Yael Wilnai; Nicoletta Zoppi; Herbert M Geller; Cecilia Giunta; Anne Slavotinek; Beat Steinmann
Journal:  Am J Med Genet A       Date:  2015-09-16       Impact factor: 2.802

3.  Brittle cornea syndrome: an heritable connective tissue disorder distinct from Ehlers-Danlos syndrome type VI and fragilitas oculi, with spontaneous perforations of the eye, blue sclerae, red hair, and normal collagen lysyl hydroxylation.

Authors:  P M Royce; B Steinmann; A Vogel; U Steinhorst; A Kohlschuetter
Journal:  Eur J Pediatr       Date:  1990-04       Impact factor: 3.183

Review 4.  Diseases of the collagen molecule.

Authors:  C I Levene
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

5.  Genotyping and prenatal assessment of collagen lysyl hydroxylase deficiency in a family with Ehlers-Danlos syndrome type VI.

Authors:  P P Dembure; J H Priest; S C Snoddy; L J Elsas
Journal:  Am J Hum Genet       Date:  1984-07       Impact factor: 11.025

6.  Aortic aneurysm in Marfan's syndrome: changes in the ultrastructure and composition of collagen.

Authors:  M Scheck; R C Siegel; J Parker; Y H Chang; J C Fu
Journal:  J Anat       Date:  1979-10       Impact factor: 2.610

7.  [Syndrome of blue sclerae and keratoglobus (ocular type of Ehlers-Danlos syndrome (author's transl)].

Authors:  W Behrens-Baumann; H J Gebauer; U Langenbeck
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1977-12-31

8.  Exclusion of COL1A1, COL1A2, and COL3A1 genes as candidate genes for Ehlers-Danlos syndrome type I in one large family.

Authors:  B P Sokolov; A N Prytkov; G Tromp; R G Knowlton; D J Prockop
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

9.  A patient with Ehlers-Danlos syndrome type VI is a compound heterozygote for mutations in the lysyl hydroxylase gene.

Authors:  V T Ha; M K Marshall; L J Elsas; S R Pinnell; H N Yeowell
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

10.  [Ehlers-Danolos syndrome: a disease of fibroblasts and collagen fibrils. Classification and electron-microscopic findings in five patients (author's transl)].

Authors:  M Sevenich; U Schultz-Ehrenburg; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.